Switchable Lipids: Conformational Change for Fast pH-Triggered Cytoplasmic Delivery†
Warren Viricel
Faculty of Pharmacy, University of Montreal, P.O. Box 6128, Downtown Station, Montreal, Quebec (Canada)
Search for more papers by this authorDr. Amira Mbarek
Faculty of Pharmacy, University of Montreal, P.O. Box 6128, Downtown Station, Montreal, Quebec (Canada)
Search for more papers by this authorCorresponding Author
Prof. Dr. Jeanne Leblond
Faculty of Pharmacy, University of Montreal, P.O. Box 6128, Downtown Station, Montreal, Quebec (Canada)
Faculty of Pharmacy, University of Montreal, P.O. Box 6128, Downtown Station, Montreal, Quebec (Canada)Search for more papers by this authorWarren Viricel
Faculty of Pharmacy, University of Montreal, P.O. Box 6128, Downtown Station, Montreal, Quebec (Canada)
Search for more papers by this authorDr. Amira Mbarek
Faculty of Pharmacy, University of Montreal, P.O. Box 6128, Downtown Station, Montreal, Quebec (Canada)
Search for more papers by this authorCorresponding Author
Prof. Dr. Jeanne Leblond
Faculty of Pharmacy, University of Montreal, P.O. Box 6128, Downtown Station, Montreal, Quebec (Canada)
Faculty of Pharmacy, University of Montreal, P.O. Box 6128, Downtown Station, Montreal, Quebec (Canada)Search for more papers by this authorThe National Sciences and Engineering Research Council of Canada (NSERC) is acknowledged for financial support. We thank Aline Mesnier and Hanaa Taleb for their contribution and Prof. Marc Servant (University of Montreal) for insightful discussions.
Abstract
We report the use of switchable lipids to improve the endosomal escape and cytosolic delivery of cell-impermeable compounds. The system is based on a conformational reorganization of the lipid structure upon acidification, as demonstrated by NMR spectroscopic studies. When incorporated in a liposome formulation, the switchable lipids triggered bilayer destabilization through fusion even in the presence of poly(ethylene glycol). We observed 88 % release of sulforhodamine B in 15 min at pH 5, and the liposome formulations demonstrated high stability at pH 7.4 for several months. By using sulforhodamine B as a model of a highly polar drug, we demonstrated fast cytosolic delivery mediated by endosomal escape in HeLa cells, and no toxicity.
Supporting Information
As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.
Filename | Description |
---|---|
ange_201504661_sm_miscellaneous_information.pdf8 MB | miscellaneous_information |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
References
- 1
- 1aO. C. Farokhzad, R. Langer, ACS Nano 2009, 3, 16–20;
- 1bT. Sun, Y. S. Zhang, B. Pang, D. C. Hyun, M. Yang, Y. Xia, Angew. Chem. Int. Ed. 2014, 53, 12320–12364; Angew. Chem. 2014, 126, 12520–12568;
- 1cQ. Yin, J. Shen, Z. Zhang, H. Yu, Y. Li, Adv. Drug Delivery Rev. 2013, 65, 1699–1715;
- 1dR. Kanasty, J. R. Dorkin, A. Vegas, D. Anderson, Nat. Mater. 2013, 12, 967–977.
- 2
- 2aV. P. Torchilin, Nat. Rev. Drug Discovery 2014, 13, 813–827;
- 2bT. Nakamura, H. Akita, Y. Yamada, H. Hatakeyama, H. Harashima, Acc. Chem. Res. 2012, 45, 1113–1121;
- 2cS. Mura, J. Nicolas, P. Couvreur, Nat. Mater. 2013, 12, 991–1003;
- 2dR. Lehner, X. Wang, M. Wolf, P. Hunziker, J. Controlled Release 2012, 161, 307–316.
- 3
- 3aW. Gao, J. M. Chan, O. C. Farokhzad, Mol. Pharm. 2010, 7, 1913–1920;
- 3bT. M. Allen, P. R. Cullis, Adv. Drug Delivery Rev. 2013, 65, 36–48;
- 3cS. Simões, J. N. Moreira, C. Fonseca, N. Düzgüneş, M. C. Pedroso de Lima, Adv. Drug Delivery Rev. 2004, 56, 947–965.
- 4
- 4aC. Marchini, D. Pozzi, M. Montani, C. Alfonsi, A. Amici, S. Candeloro De Sanctis, M. A. Digman, S. Sanchez, E. Gratton, H. Amenitsch, A. Fabbretti, C. O. Gualerzi, G. Caracciolo, Cancer Gene Ther. 2011, 18, 543–552;
- 4bS. R. Paliwal, R. Paliwal, S. P. Vyas, Drug Delivery 2015, 22, 231–242.
- 5
- 5aA. G. Kohli, P. H. Kierstead, V. J. Venditto, C. L. Walsh, F. C. Szoka, J. Controlled Release 2014, 190, 274–287;
- 5bX.-X. Zhang, T. J. McIntosh, M. W. Grinstaff, Biochimie 2012, 94, 42–58;
- 5cP. T. Wong, S. K. Choi, Chem. Rev. 2015, 115, 3388–3432;
- 5dC. L. Chan, R. N. Majzoub, R. S. Shirazi, K. K. Evert, K. S. Liang, C. R. Safinya, Biomaterials 2012, 33, 4928–4935.
- 6
- 6aR. Tachibana, H. Harashima, M. Shono, M. Azumano, M. Niwa, S. Futaki, H. Kiwada, Biochem. Biophys. Res. Commun. 1998, 251, 538–544;
- 6bT. Yoshimura, M. Shono, K. Imai, K. Hong, J. Biochem. 1995, 117, 34–41;
- 6cJ. Shin, P. Shum, J. Grey, S. Fujiwara, G. S. Malhotra, A. González-Bonet, S.-H. Hyun, E. Moase, T. M. Allen, D. H. Thompson, Mol. Pharm. 2012, 9, 3266–3276.
- 7
- 7aR. Mo, T. Jiang, Z. Gu, Angew. Chem. Int. Ed. 2014, 53, 5815–5820; Angew. Chem. 2014, 126, 5925–5930;
- 7bJ. O. Onyango, M. S. Chung, C.-H. Eng, L. M. Klees, R. Langenbacher, L. Yao, M. An, Angew. Chem. Int. Ed. 2015, 54, 3658–3663; Angew. Chem. 2015, 127, 3729–3734;
- 7cJ. P. M. Motion, J. Nguyen, F. C. Szoka, Angew. Chem. Int. Ed. 2012, 51, 9047–9051; Angew. Chem. 2012, 124, 9181–9185;
- 7dL. D. Field, J. B. Delehanty, Y. Chen, I. L. Medintz, Acc. Chem. Res. 2015, 48, 1380–1390;
- 7eK. Boeneman, J. B. Delehanty, J. B. Blanco-Canosa, K. Susumu, M. H. Stewart, E. Oh, A. L. Huston, G. Dawson, S. Ingale, R. Walters, M. Domowicz, J. R. Deschamps, W. R. Algar, S. DiMaggio, J. Manono, C. M. Spillmann, D. Thompson, T. L. Jennings, P. E. Dawson, I. L. Medintz, ACS Nano 2013, 7, 3778–3796.
- 8
- 8aM. A. Quadir, S. W. Morton, Z. J. Deng, K. E. Shopsowitz, R. P. Murphy, T. H. Epps, P. T. Hammond, Mol. Pharm. 2014, 11, 2420–2430;
- 8bE. Yuba, A. Harada, Y. Sakanishi, K. Kono, J. Controlled Release 2011, 149, 72–80;
- 8cE. Yuba, N. Tajima, Y. Yoshizaki, A. Harada, H. Hayashi, K. Kono, Biomaterials 2014, 35, 3091–3101;
- 8dA. E. Felber, M.-H. Dufresne, J.-C. Leroux, Adv. Drug Delivery Rev. 2012, 64, 979–992.
- 9
- 9aX.-X. Zhang, C. A. H. Prata, J. A. Berlin, T. J. McIntosh, P. Barthelemy, M. W. Grinstaff, Bioconjugate Chem. 2011, 22, 690–699;
- 9bS. C. Semple et al., Nat. Biotechnol. 2010, 28, 172–176;
- 9cT. Gjetting, R. I. Jølck, T. L. Andresen, Adv. Healthcare Mater. 2014, 3, 1107–1118.
- 10
- 10aS. Mishra, P. Webster, M. E. Davis, Eur. J. Cell Biol. 2004, 83, 97–111;
- 10bK. Knop, R. Hoogenboom, D. Fischer, U. S. Schubert, Angew. Chem. Int. Ed. 2010, 49, 6288–6308; Angew. Chem. 2010, 122, 6430–6452;
- 10cH. Xu, J. W. Paxton, Z. Wu, Pharm. Res. 2015, 32, 2428–2438.
- 11
- 11aX. Liu, Y. Zheng, N. M. Samoshina, A. H. Franz, X. Guo, V. V. Samoshin, J. Liposome Res. 2012, 22, 319–328;
- 11bE. Mamasheva, C. O’Donnell, A. Bandekar, S. Sofou, Mol. Pharm. 2011, 8, 2224–2232.
- 12
- 12aY. Dong et al., Proc. Natl. Acad. Sci. USA 2014, 111, 3955–3960;
- 12bB. Schultheis, D. Strumberg, A. Santel, C. Vank, F. Gebhardt, O. Keil, C. Lange, K. Giese, J. Kaufmann, M. Khan, J. Drevs, J. Clin. Oncol. 2014, 32, 4141–4148.
- 13
- 13aJ. Leblond, A. Petitjean, ChemPhysChem 2011, 12, 1043–1051;
- 13bM. Hardouin–Lerouge, P. Hudhomme, M. Sallé, Chem. Soc. Rev. 2010, 40, 30–43.
- 14
- 14aD. Bier, R. Rose, K. Bravo-Rodriguez, M. Bartel, J. M. Ramirez-Anguita, S. Dutt, C. Wilch, F.-G. Klärner, E. Sanchez-Garcia, T. Schrader, C. Ottmann, Nat. Chem. 2013, 5, 234–239;
- 14bV. V. Samoshin, Biomol. Concepts 2014, 5, 131–141.
- 15J. Leblond, H. Gao, A. Petitjean, J.-C. Leroux, J. Am. Chem. Soc. 2010, 132, 8544–8545.
- 16J. R. Casey, S. Grinstein, J. Orlowski, Nat. Rev. Mol. Cell Biol. 2010, 11, 50–61.
- 17L. Yao, J. Daniels, D. Wijesinghe, O. A. Andreev, Y. K. Reshetnyak, J. Controlled Release 2013, 167, 228–237.
- 18
- 18aH.-K. Kim, J. Van den Bossche, S.-H. Hyun, D. H. Thompson, Bioconjugate Chem. 2012, 23, 2071–2077;
- 18bH. Chen, H. Zhang, D. Thor, R. Rahimian, X. Guo, Eur. J. Med. Chem. 2012, 52, 159–172;
- 18cW. Chen, F. Meng, R. Cheng, Z. Zhong, J. Controlled Release 2010, 142, 40–46.
- 19
- 19aI. Tomatsu, H. R. Marsden, M. Rabe, F. Versluis, T. Zheng, H. Zope, A. Kros, J. Mater. Chem. 2011, 21, 18927–18933;
- 19bŽ. Vanić, S. Barnert, R. Süss, R. Schubert, J. Liposome Res. 2011, 22, 148–157.
- 20
- 20aM. Musial-Siwek, A. Karabadzhak, O. A. Andreev, Y. K. Reshetnyak, D. M. Engelman, Biochim. Biophys. Acta Biomembr. 2010, 1798, 1041–1046;
- 20bJ. Fendos, F. N. Barrera, D. M. Engelman, Biochemistry 2013, 52, 4595–4604.
- 21R. J. Lee, S. Wang, M. J. Turk, P. S. Low, Biosci. Rep. 1998, 18, 69–78.
Citing Literature
This is the
German version
of Angewandte Chemie.
Note for articles published since 1962:
Do not cite this version alone.
Take me to the International Edition version with citable page numbers, DOI, and citation export.
We apologize for the inconvenience.